Hydroxychloroquine Market, By Disease Type (Coronavirus Disease (COVID-19), Malaria, Q Fever, Rheumatoid Arthritis, Lupus Erythematosus, Porphyria Cutanea Tarda (PCT), and Other Disease Types), By Distribution Channel (Specialty Drug Store, Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2029

India's hydroxychloroquine output is growing.

India is a significant producer and supplier of hydroxychloroquine. It is increasing its output to satisfy growing demand from several nations, notably the United States of America. Nine metric tons of API, active pharmaceutical ingredients, and around 3 million pill versions of the medication are being supplied by India to the USA. Cipla, McW Healthcare of Indore, Macleods Pharmaceuticals, and Intas Pharmaceuticals are a few of the leading manufacturers in the Indian market.

Producers are increasing their output levels.

The increasing demand from end users worldwide presents significant growth prospects for producers and suppliers in the target market. Prominent producers, including Novartis, Teva, Mylan, and others, have given away free hydroxychloroquine medications to treat COVID-19 patients. The production of Ipca Laboratories Ltd. has increased by 20 tons monthly. On the other hand, Laurus Labs has added 5 tons to its production capacity. Furthermore, some businesses have committed to donating millions of hydroxychloroquine pills to their respective regions, including Laurus Labs, Bayer, Sun Pharma, and others.